{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:28:52Z","timestamp":1787030932014,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0019-5154.193680","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T02:23:45Z","timestamp":1478658225000},"page":"664","source":"Crossref","is-referenced-by-count":2,"title":["The relationship of psoriasis and melanocytic nevi"],"prefix":"10.4103","volume":"61","author":[{"given":"FatmaPelin","family":"Cengiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazan","family":"Emiroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnilGulsel","family":"Bahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DilekBiyik","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahide","family":"Onsun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.193680-1","first-page":"496","volume-title":"Psoriasis","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-5154.193680-2","first-page":"563","volume-title":"Psoriasis and the metabolic syndrome","author":"Gottlieb","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0019-5154.193680-3","first-page":"121","volume-title":"Psoriasis comorbidities: Results from the National Psoriasis Foundation surveys 2003 to 2011","author":"Armstrong","year":"2012","journal-title":"Dermatology"},{"key":"key-10.4103\/0019-5154.193680-4","first-page":"383","volume-title":"The psychosocial burden of psoriasis","author":"Kimball","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0019-5154.193680-5","first-page":"2604","volume-title":"Psoriasis and risk of incident cancer: An inception cohort study with a nested case-control analysis","author":"Brauchli","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.193680-6","first-page":"1003","volume-title":"Association between psoriasis and incident cancer: The Iowa\u2032s women\u2032s health study","author":"Prizment","year":"2011","journal-title":"Cancer Causes Control"},{"key":"key-10.4103\/0019-5154.193680-7","first-page":"1531","volume-title":"Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden","author":"Boffetta","year":"2001","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.193680-8","first-page":"1582","volume-title":"Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA).A meta-analysis","author":"Stern","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.193680-9","first-page":"2759","volume-title":"The carcinogenic risk of treatments for severe psoriasis.Photochemotherapy follow-up study","author":"Stern","year":"1994","journal-title":"Cancer"},{"key":"key-10.4103\/0019-5154.193680-10","first-page":"755","volume-title":"The risk of melanoma in association with long-term exposure to PUVA","author":"Stern","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.193680-11","first-page":"1499","volume-title":"Cancer risk in hospitalised psoriasis patients: A follow-up study in Sweden","author":"Ji","year":"2009","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0019-5154.193680-12","first-page":"1262","volume-title":"Psoriasis and melanocytic naevi: Does the first confer a protective role against melanocyte progression to naevi?","author":"Balato","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.193680-13","first-page":"947","volume-title":"Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity","author":"Di","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.193680-14","first-page":"1339","volume-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","author":"Di","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.193680-15","first-page":"180","volume-title":"Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis","author":"Swope","year":"1991","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.193680-16","first-page":"880","volume-title":"Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals","author":"Bovenschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.193680-17","first-page":"277","volume-title":"Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: Cause or coincidence?","author":"Finet","year":"2013","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/0019-5154.193680-18","first-page":"e78","volume-title":"Rapidly progressive malignant melanoma in a patient treated with tocilizumab","author":"Bonny","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.193680-19","first-page":"e18907","volume-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/0019-5154.193680-20","first-page":"219","volume-title":"Dysregulation of melanocyte function by Th17-related cytokines: Significance of Th17 cell infiltration in autoimmune vitiligo vulgaris","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0019-5154.193680-21","first-page":"971","volume-title":"Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation","author":"Mart\u00ednez-Esparza","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"key-10.4103\/0019-5154.193680-22","first-page":"664","volume-title":"Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: A pivotal role of CD8+cytotoxic T lymphocytes in vitiligo","author":"Yang","year":"2015","journal-title":"Acta Derm Venereol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,11,13]],"date-time":"2016-11-13T22:42:28Z","timestamp":1479076948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.e-ijd.org\/text.asp?2016\/61\/6\/664\/193680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"alternative-id":["193680"],"URL":"https:\/\/doi.org\/10.4103\/0019-5154.193680","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}